IMS Capital Management lifted its stake in Danaher Co. (NYSE:DHR) by 31.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,897 shares of the conglomerate’s stock after buying an additional 700 shares during the period. IMS Capital Management’s holdings in Danaher were worth $418,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Barings LLC raised its stake in Danaher by 8.7% during the second quarter. Barings LLC now owns 11,922 shares of the conglomerate’s stock valued at $1,703,000 after buying an additional 952 shares in the last quarter. Capital Advisors Ltd. LLC raised its position in shares of Danaher by 527.5% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 320 shares of the conglomerate’s stock worth $46,000 after purchasing an additional 269 shares during the period. Rehmann Capital Advisory Group raised its position in shares of Danaher by 11.1% during the 1st quarter. Rehmann Capital Advisory Group now owns 2,014 shares of the conglomerate’s stock worth $266,000 after purchasing an additional 202 shares during the period. Sullivan Bruyette Speros & Blaney LLC raised its position in shares of Danaher by 5.2% during the 2nd quarter. Sullivan Bruyette Speros & Blaney LLC now owns 14,598 shares of the conglomerate’s stock worth $2,086,000 after purchasing an additional 717 shares during the period. Finally, Wafra Inc. raised its position in shares of Danaher by 1,242.9% during the 1st quarter. Wafra Inc. now owns 258,892 shares of the conglomerate’s stock worth $34,179,000 after purchasing an additional 239,613 shares during the period. 78.42% of the stock is owned by institutional investors.

DHR traded up $1.78 during trading hours on Thursday, hitting $137.40. The company’s stock had a trading volume of 47,419 shares, compared to its average volume of 2,433,457. Danaher Co. has a fifty-two week low of $94.59 and a fifty-two week high of $147.33. The company has a current ratio of 2.32, a quick ratio of 1.91 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $100.20 billion, a PE ratio of 30.40, a PEG ratio of 2.34 and a beta of 0.94. The company has a 50-day simple moving average of $141.11 and a 200 day simple moving average of $137.26.

Danaher (NYSE:DHR) last posted its earnings results on Thursday, July 18th. The conglomerate reported $1.19 EPS for the quarter, beating the consensus estimate of $1.15 by $0.04. The firm had revenue of $5.16 billion for the quarter, compared to analysts’ expectations of $5.09 billion. Danaher had a return on equity of 11.53% and a net margin of 12.22%. The firm’s revenue was up 3.5% compared to the same quarter last year. During the same period last year, the firm earned $1.15 EPS. Research analysts expect that Danaher Co. will post 4.79 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Friday, September 27th will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.49%. The ex-dividend date is Thursday, September 26th. Danaher’s payout ratio is currently 15.04%.

A number of brokerages have recently weighed in on DHR. Robert W. Baird increased their price target on Danaher from $131.00 to $148.00 and gave the stock an “outperform” rating in a research report on Friday, July 19th. Piper Jaffray Companies increased their price target on Danaher from $148.00 to $153.00 and gave the stock a “neutral” rating in a research report on Thursday, July 18th. Royal Bank of Canada set a $134.00 price target on Danaher and gave the stock a “hold” rating in a research report on Friday, July 19th. ValuEngine cut Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, Argus raised their target price on Danaher to $165.00 and gave the company a “buy” rating in a research report on Tuesday, July 23rd. Four analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $144.50.

In other Danaher news, EVP Daniel L. Comas sold 68,379 shares of the stock in a transaction on Friday, July 19th. The stock was sold at an average price of $142.05, for a total transaction of $9,713,236.95. Following the completion of the transaction, the executive vice president now directly owns 187,474 shares of the company’s stock, valued at approximately $26,630,681.70. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Chairman Mitchell P. Rales purchased 2,500 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were purchased at an average cost of $139.52 per share, with a total value of $348,800.00. Following the completion of the purchase, the chairman now owns 3,030,453 shares in the company, valued at approximately $422,808,802.56. The disclosure for this purchase can be found here. Over the last ninety days, insiders have sold 177,202 shares of company stock valued at $25,175,829. 11.40% of the stock is currently owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Read More: How to invest using market indexes

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.